Ignite Creation Date:
2024-05-06 @ 2:12 PM
Last Modification Date:
2024-10-26 @ 1:27 PM
Study NCT ID:
NCT04247165
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-05-28
First Post:
2020-01-25
Brief Title:
Nivolumab Ipilimumab and Chemoradiation in Pancreatic Cancer
Sponsor:
Herlev Hospital
Organization:
Herlev Hospital
Organization Data
Organization:
Herlev Hospital
Class:
OTHER
Study ID:
GI 1931
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Herlev Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
Inna Chen MD
Responsible Party Title:
Principal investigator
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Herlev Hospital
Old Name:
None
Old Organization:
None